Skip to main content

Advertisement

Table 4 Diagnostic odds ratio (dOR) calculated for each immunohistochemistry marker or combination

From: Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis

IHC ANALYSIS dOR (95% CI) Q P
CK-19[10, 1433] 14.73 (8.20-26.45) 110.05 <0.00001
GAL-3[10, 1417, 19, 21, 2556] 23.41 (14.02-39.07) 252.72 <0.00001
HBME-1[10, 1419, 21, 2427, 29, 30, 41, 51, 5761] 40.97 (21.42-78.37) 140.82 <0.00001
CK-19 + HBME-1[14, 17] 119.06 (6.81-2080.37) 2.62 0.1058
GAL-3 + CK-19[14, 17] 86.54 (10.8-693.52) 2.89 0.8292
GAL-3 + HBME-1[14, 17, 46, 51] 21.94 (2.88-167.49) 21.16 0.0001
GAL-3 + HBME-1 + CK-19[14, 17, 29] 95.06 (25.17-359.08) 2.23 0.3280